The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2020

Filed:

Mar. 23, 2017
Applicant:

Toyo University, Tokyo, JP;

Inventors:

Toru Maekawa, Kawagoe, JP;

Sakthikumar Dasappan Nair, Kawagoe, JP;

Sheikh Mohamed Mohamed, Kawagoe, JP;

Srivani Veeranarayanan, Kawagoe, JP;

Assignee:

TOYO UNIVERSITY, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/51 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01); A61K 47/42 (2017.01); A61K 49/00 (2006.01); A61K 9/16 (2006.01); A61K 45/00 (2006.01); A61P 35/00 (2006.01); A61K 38/16 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 9/5123 (2013.01); A61K 9/16 (2013.01); A61K 9/5169 (2013.01); A61K 9/5192 (2013.01); A61K 38/168 (2013.01); A61K 45/00 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/24 (2013.01); A61K 47/42 (2013.01); A61K 49/00 (2013.01); A61P 35/00 (2018.01); A61K 49/0004 (2013.01); B82Y 5/00 (2013.01);
Abstract

Provided is a composition which can be utilized for drug delivery systems that can penetrate the blood brain barrier, and has low cytotoxicity. A nanoparticle composition comprises nanoparticles to the surface of which a first substance and a second substance each having specificity to a tumor cell are bound, wherein the first substance having specificity to the tumor cell is a peptide comprising an amino acid sequence of arginine-glycine-aspartic acid, and wherein the second substance having specificity to the tumor cell is an iron-binding protein, and wherein the nanoparticles each comprise an outer layer and vesicles enveloped by the outer layer and the nanoparticles each comprise, as membrane components, a PEGylated phospholipid, a fatty acid with a melting point of 30° C. or more, and a non-PEGylated phospholipid.


Find Patent Forward Citations

Loading…